127 related articles for article (PubMed ID: 18709732)
1. [Prophylactic use of oral itraconazole solution for febrile neutropenia associated with hematologic malignancies].
Nakagawa Y; Suzuki N
Jpn J Antibiot; 2008 Apr; 61(2):102-4. PubMed ID: 18709732
[No Abstract] [Full Text] [Related]
2. [Efficacy of itraconazole injections for treatment of febrile neutropenia].
Saito T; Inoue Y; Kato A; Takimoto M; Suzuki T; Iyoshi N; Arai T; Shibuya Y; Suzuki Y; Kato M; Takahashi M; Miura I; Ogawa K
Jpn J Antibiot; 2008 Apr; 61(2):95-8. PubMed ID: 18709730
[No Abstract] [Full Text] [Related]
3. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
Kim JS; Cheong JW; Kim YK; Park J; Mun YC; Kang HJ; Yi HG; Lee JH; Kim YS; Ryoo HM; Kim SH; Kim HY; Kim JY; Lee DG; Kim HG; Kim H; Joo YD; Min YH
Ann Hematol; 2014 Jan; 93(1):33-42. PubMed ID: 23807252
[TBL] [Abstract][Full Text] [Related]
4. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
5. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
[TBL] [Abstract][Full Text] [Related]
6. [Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
Andrade M A; Puga L B; Guerra C C; Molina E J; Capurro C M
Rev Med Chil; 2011 Sep; 139(9):1128-34. PubMed ID: 22215390
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of itraconazole solution used as prophylaxis for febrile neutropenia.
Kanbayashi Y; Nomura K; Fujimoto Y; Shimura K; Shimizu D; Okamoto K; Matsumoto Y; Horiike S; Shimazaki C; Takagi T; Taniwaki M
Int J Antimicrob Agents; 2008 May; 31(5):452-7. PubMed ID: 18359202
[TBL] [Abstract][Full Text] [Related]
8. Antifungal prophylaxis in neutropenic patients with hematologic malignancies.
Böhme A; Karthaus M; Hoelzer D
Antibiot Chemother (1971); 2000; 50():69-78. PubMed ID: 10874456
[No Abstract] [Full Text] [Related]
9. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Glasmacher A; Prentice AG
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
[TBL] [Abstract][Full Text] [Related]
10. [Improvement of patient adherence by mixing oral itraconazole solution with a beverage (orange juice)].
Adachi Y; Sumikuma T; Kagami R; Nishio A; Akasaka K; Tsunemine H; Kodaka T; Hiramatsu Y; Tada H
Rinsho Ketsueki; 2010 May; 51(5):315-9. PubMed ID: 20534951
[TBL] [Abstract][Full Text] [Related]
11. Comment to the article of C. C. Kibbler: antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
Silling G
Mycoses; 1999; 42 Suppl 2():124. PubMed ID: 10865919
[No Abstract] [Full Text] [Related]
12. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
[TBL] [Abstract][Full Text] [Related]
13. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of itraconazole for systemic fungal infections complicated with hematological malignancies--multicenter cooperative study. West-Japan Systemic Fungal Infection Study Group].
Shiku H; Horiuchi A; Kuramoto A; Harada M; Niho Y
Kansenshogaku Zasshi; 1998 Nov; 72(11):1208-18. PubMed ID: 9884508
[TBL] [Abstract][Full Text] [Related]
15. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
[TBL] [Abstract][Full Text] [Related]
16. D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.
Kanda Y; Kimura SI; Iino M; Fukuda T; Sakaida E; Oyake T; Yamaguchi H; Fujiwara SI; Jo Y; Okamoto A; Fujita H; Takamatsu Y; Saburi Y; Matsumura I; Yamanouchi J; Shiratori S; Gotoh M; Nakamura S; Tamura K;
J Clin Oncol; 2020 Mar; 38(8):815-822. PubMed ID: 31977270
[TBL] [Abstract][Full Text] [Related]
17. [Effect of prophylaxis against myocosis in patients with hematological malignancy disease: efficacy of dosage of itraconazole].
Toubai T; Tanaka J; Fujisawa F; Kondo Y; Imamura M; Ota S; Hashino S; Yonetumi M; Chiba K; Kondo T; Toyoshima N; Asaka M
Jpn J Antibiot; 2003 Feb; 56(1):61-5. PubMed ID: 12723400
[TBL] [Abstract][Full Text] [Related]
18. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto.
Menichetti F; Del Favero A; Martino P; Bucaneve G; Micozzi A; Girmenia C; Barbabietola G; Pagańo L; Leoni P; Specchia G; Caiozzo A; Raimondi R; Mandelli F
Clin Infect Dis; 1999 Feb; 28(2):250-5. PubMed ID: 10064240
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
Nucci M; Biasoli I; Akiti T; Silveira F; Solza C; Barreiros G; Spector N; Derossi A; Pulcheri W
Clin Infect Dis; 2000 Feb; 30(2):300-5. PubMed ID: 10671332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]